Times Reporter of Africa: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Times Reporter of Africa.

Press releases published on March 9, 2026

Mar. 9, 2026

Tenaya Therapeutics Presents Preclinical Data at MDA 2026 Highlighting TN-301’s Potential to Correct Skeletal and Cardiac Muscle Decline in Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire

Mar. 9, 2026

Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss

Indeterminate GlobeNewswire

Mar. 9, 2026

NovelMed Therapeutics Announces Regulatory Clearance for Subcutaneous Ruxoprubart and Reports Positive Phase II Intravenous Monotherapy Results in PNH

Indeterminate GlobeNewswire

Mar. 9, 2026

Nasus Pharma to Present and Participate in the Upcoming Life Sciences Investor Forum

Indeterminate GlobeNewswire

Mar. 9, 2026

Galecto Announces Name Change to Damora Therapeutics with Mission to Fundamentally Redefine Care for Patients with Blood Disorders

Indeterminate GlobeNewswire

Mar. 9, 2026

Cue Biopharma to Present New In vitro Data for CUE-401 at the 20th World Immune Regulation Meeting (WIRM) 2026

Indeterminate GlobeNewswire

Mar. 9, 2026

First Subjects Dosed in Cocrystal Pharma’s Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment

Indeterminate GlobeNewswire

Mar. 9, 2026

Keros Therapeutics Announces Collaboration with Sean M. Healey & AMG Center for ALS

Indeterminate GlobeNewswire

Mar. 9, 2026

Keros Therapeutics Presents Additional Clinical Data from Its Rinvatercept Program at the 2026 MDA Clinical & Scientific Conference

Indeterminate GlobeNewswire

Mar. 9, 2026

Lyell Immunopharma Announces Closing of Additional $50 Million Tranche of Equity Private Placement and Appointment of Smital Shah as Chief Financial and Business Officer 

Indeterminate GlobeNewswire

Mar. 9, 2026

Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Indeterminate GlobeNewswire

Mar. 9, 2026

Skyharbour JV Partner Denison Mines Commences Winter Drill Program at the Wheeler North Joint Venture in Northern Saskatchewan

Indeterminate GlobeNewswire

Mar. 9, 2026

Rapport Therapeutics and Tenacia Biotechnology Announce Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China

Indeterminate GlobeNewswire

Mar. 9, 2026

Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 Treatment at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference

Indeterminate GlobeNewswire

Mar. 9, 2026

MEXC Foundation Co-Hosts International Women's Day Workshop in Sydney

Indeterminate GlobeNewswire

Mar. 9, 2026

TRX Gold Reports 2026 Annual Meeting Voting Results

Indeterminate GlobeNewswire

Mar. 9, 2026

MEXC Publishes January-February Bimonthly Security Report: $4.09M in Intercepted Fraud, 267% Bitcoin Reserve Coverage

Indeterminate GlobeNewswire

Mar. 9, 2026

MEXC Publishes January-February Bimonthly Security Report: $4.09M in Intercepted Fraud, 267% Bitcoin Reserve Coverage

Indeterminate GlobeNewswire

Mar. 9, 2026

MEXC Launches ETH Launchpad With 50% Discount for New Users

Indeterminate GlobeNewswire

Mar. 9, 2026

HUTCHMED Announces Update on Licensed Oncology Product TAZVERIK® in China

Indeterminate GlobeNewswire